Johnson & Johnson Total Long Term Liabilities 2010-2025 | JNJ

Johnson & Johnson total long term liabilities for the quarter ending March 31, 2025 were $58.659B, a 10.22% increase year-over-year.

  • Johnson & Johnson total long term liabilities for 2024 were $58.293B, a 11.03% increase from 2023.
  • Johnson & Johnson total long term liabilities for 2023 were $52.502B, a 4.14% decline from 2022.
  • Johnson & Johnson total long term liabilities for 2022 were $54.772B, a 12.74% decline from 2021.

Johnson & Johnson Total Long Term Liabilities 2010-2025 | JNJ

  • Johnson & Johnson total long term liabilities for 2024 were $58.293B, a 11.03% increase from 2023.
  • Johnson & Johnson total long term liabilities for 2023 were $52.502B, a 4.14% decline from 2022.
  • Johnson & Johnson total long term liabilities for 2022 were $54.772B, a 12.74% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B